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  W
e would be lying if we said 
that our journal’s impending 
ﬁ  rst impact factor is not of 
interest to us. What   PLoS Medicine  ’s 
impact factor might be is certainly one 
of the questions that crops up most 
regularly in discussions with authors, 
and because our authors’ opinions 
matter to us, we are obliged to take 
it seriously. However, for a number 
that is so widely used and abused, it is 
surprising how few people understand 
how a journal’s impact factor is 
calculated, and, more importantly, just 
how limited it is a means of assessing 
the true impact of an individual 
publication in that journal. 
    A journal’s impact factor is 
calculated from this equation: 
    Journal X’s 2005 impact factor =
    Citations in 2005 (in journals indexed 
by Thomson Scientiﬁ  c [formerly 
known as Thomson ISI]) to all articles 
published by Journal X in 2003–2004
    divided by
    Number of articles deemed to be 
“citable” by Thomson Scientiﬁ  c that 
were published in Journal X in 2003–
2004
    What is obvious from this equation is 
that the impact factor depends crucially 
on which article types Thomson 
Scientiﬁ  c deems as “citable”—the 
fewer, the better (i.e., the lower the 
denominator, the higher the impact 
factor). 
    Because a journal’s impact factor is 
derived from citations to all articles 
in a journal, this number cannot 
tell us anything about the quality of 
any speciﬁ  c research article in that 
journal, nor of the quality of the 
work of any speciﬁ  c author. These 
points become particularly evident 
by understanding that a journal’s 
impact factor can be substantially 
affected by the publication of review 
articles (which usually acquire more 
citations than research articles) or the 
publication of just a few very highly 
cited research papers.
    Moreover, a journal’s impact factor 
says nothing at all about how well read 
and discussed the journal is outside the 
core scientiﬁ  c community or whether it 
inﬂ  uences health policy. For a journal 
such as   PLoS Medicine  , which strives to 
make our open-access content reach 
the widest possible audience—such 
as patients, health policy makers, 
non-governmental organizations, and 
school teachers—impact factor is a 
poor measure of overall impact. 
    Despite these evident limitations, 
the impact factors of journals that 
authors publish in are very inﬂ  uential. 
Although even Thomson Scientiﬁ  c 
acknowledges that the impact factor 
has grown beyond its control and is 
being used in many inappropriate 
ways, the impact factors of journals 
have been used to decide whether or 
not authors get promoted, are given 
tenure or are offered a position in a 
department, or are awarded a grant. In 
some countries, government funding of 
entire institutions is dependent on the 
number of publications in journals with 
high impact factors. 
    Small wonder, then, that authors 
care so much about journals’ 
impact factors and take them into 
consideration when submitting papers. 
Should we, as the editors of   PLoS 
Medicine  , also care about our impact 
factor and do all we can to increase 
it? This is not a theoretical question; 
it is well known that editors at many 
journals plan and implement strategies 
to massage their impact factors. Such 
strategies include attempting to 
increase the numerator in the above 
equation by encouraging authors to 
cite articles published in the journal 
or by publishing reviews that will 
garner large numbers of citations. 
Alternatively, editors may decrease the 
denominator by attempting to have 
whole article types removed from it 
(by making such articles superﬁ  cially 
less substantial, such as by forcing 
authors to cut down on the number of 
references or removing abstracts) or 
by decreasing the number of research 
articles published. These are just a 
few of the many ways of “playing the 
impact factor game.” 
    One problem with this game, leaving 
aside the ethics of it, is that the rules 
are unclear—editors can, for example, 
try to persuade Thomson Scientiﬁ  c 
to reduce the denominator, but the 
company refuses to make public 
its process for choosing “citable” 
article types. Thomson Scientiﬁ  c, 
the sole arbiter of the impact factor 
game, is part of The Thomson 
Corporation, a for-proﬁ  t organization 
that is responsible primarily to its 
shareholders. It has no obligation to be 
accountable to any of the stakeholders 
who care most about the impact 
factor—the authors and readers of 
scientiﬁ  c research. Although we have 
not attempted to play this game, we 
did, because of the value that authors 
place on it, attempt to understand 
the rules. During discussions with 
Thomson Scientiﬁ  c over which article 
types in   PLoS Medicine   the company 
deems as “citable,” it became clear that 
the process of determining a journal’s 
impact factor is unscientiﬁ  c and 
arbitrary. After one in-person meeting, 
a telephone conversation, and a ﬂ  urry 
of e-mail exchanges, we came to realize 
that Thomson Scientiﬁ  c has no explicit 
process for deciding which articles 
other than original research articles 
it deems as citable. We conclude that 
science is currently rated by a process 
that is itself unscientiﬁ  c, subjective, and 
secretive. 
    During the course of our discussions 
with Thompson Scientiﬁ  c,   PLoS 
Medicine  ’s potential impact factor—
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same year  —seesawed between as much 
as 11 (when only research articles are 
entered into the denominator) to less 
than 3 (when almost all article types in 
the magazine section are included, as 
Thomson Scientiﬁ  c had initially done—
wrongly, we argued, when comparing 
such article types with comparable ones 
published by other medical journals). 
At the time of writing this editorial, we 
do not know exactly where our 2005 
impact factor has settled. But whatever 
it turns out to be, as you might guess 
from this editorial, we feel the time has 
come for the process of “deciding” a 
journal’s impact factor to be debated 
openly. Something that affects so many 
people’s careers and the future of 
departments and institutions cannot be 
kept a secret any longer. 
    Even more importantly, it is time 
to reconsider the whole process of 
accurately assessing an individual 
paper’s worth not only to scientists, 
but also to the wider community of 
readers. First, although any measure 
of impact will remain ﬂ  awed in some 
way, when assessing the impact of 
individual articles or of the papers of 
individuals or groups of scientists, it 
surely makes more sense to measure 
the citations speciﬁ  cally to those 
individual articles (or to papers by 
individuals or groups of scientists) 
rather than using a journal’s impact 
factor as a proxy measure. However, it 
is not clear whether Thomson Scientiﬁ  c 
could measure such individual article 
citations accurately. Second, we urge 
the company to take its responsibility 
seriously and increase transparency 
and accountability. Third, we suggest 
that the company’s staff engage in 
the ongoing debate among other 
shareholders of scientiﬁ  c publishing 
and recognize that, there are—ﬁ  nally—
other ways of measuring impact and 
visibility of scholarly articles. Thomson 
Scientiﬁ  c now faces competition from 
organizations that have developed 
online tools for citation counting, 
such as Google Scholar and CrossRef, 
and this competition may help to 
bring about overdue change. Other 
measures of scientiﬁ  c impact may also 
become widely adopted, such as the 
usage factor, which is being promoted 
by the United Kingdom Serials Group 
(http:⁄⁄www.uksg.org/rfp.pdf), or 
the Y factor, a combination of both 
the impact factor and the weighted 
page rank, developed by Google 
(http:⁄⁄www.soe.ucsc.edu/~okram/
papers/journal-status.pdf).
    These new measures may go some 
way to helping assess and perhaps 
quantify the many roles that medical 
journals have, in a way that measuring 
citations only to research articles 
cannot. Magazine sections, such as 
those that we and other medical 
journals publish, not only “add value” 
to the research articles by interpreting 
them for a wider audience but have 
other vital roles: they may help to set 
agendas—by publishing policy papers 
or highlighting neglected health issues; 
give underrepresented groups, such as 
medical students or patient groups, a 
voice; or provide educational materials 
to physicians. Such articles will rarely 
be cited in indexed journals, but may 
be inﬂ  uential, for example, in changing 
health policy, or may be of educational 
value. For such articles, more relevant 
measures of impact may be the number 
of times they are downloaded, or 
covered in news articles, or referenced 
in policy documents. 
    Perhaps even measures such as 
these will become outmoded as the 
Internet allows for users to interact 
more directly with published articles. 
Journals have taken a step toward such 
a future with the publication of e-
letters, and the physics preprint server 
arXiv.org has been promoting such 
interaction for many years. As more 
and more articles are available in full 
electronically and as search engines get 
more sophisticated at mining the Web 
and assessing usage, such interaction 
with the literature will become easier 
and readers will be able to judge papers 
for themselves rather than relying on 
outmoded surrogates for quality such 
as the impact factor. If authors are 
going to quote the impact factor of a 
journal, they should understand what it 
can and cannot measure. The opening 
up of the literature means that better 
ways of assessing papers and journals 
are coming—and we should embrace 
them.   
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